Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-64,300
Closed -$1.65M 4890
2024
Q1
$1.65M Buy
+64,300
New +$1.61M ﹤0.01% 2773
2023
Q3
Sell
-154,000
Closed -$3.61M 4530
2023
Q2
$3.61M Sell
154,000
-91,000
-37% -$1.54M ﹤0.01% 2122
2023
Q1
$2.91M Buy
+245,000
New +$3.49M ﹤0.01% 2404
2022
Q1
Sell
-9,200
Closed -$264K 5997
2021
Q4
$264K Hold
9,200
﹤0.01% 4741
2021
Q3
$370K Buy
+9,200
New +$411K ﹤0.01% 4245

Other funds holding XP

David Shaw's XP Position: Q2 2026 in Review

David Shaw increased its XP (XP) stake by 79% in Q2 2026, buying an estimated $1.49M and bringing the position to 189,138 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

David Shaw first reported a position in XP in Q1 2020 and has held it in 14 quarters since. The position peaked at $92M in Q4 2023. 319 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • David Shaw held 189,138 shares of XP worth $3.08M as of Q2 2026.
  • David Shaw bought 83,606 XP shares in Q2 2026, an estimated $1.49M.
  • XP made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2820 holding.
  • David Shaw first reported a position in XP in Q1 2020 and has held it in 14 quarters since.
  • David Shaw's XP position peaked at $92M in Q4 2023.
  • 319 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.